1459PD - Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)

J.F Vansteenkiste, J Naidoo + Show 13 more

Open Access

https://doi.org/10.1093/annonc/mdz259.002

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2019
Citations: 12	License type: publisher-specific-oa

Affiliation: KU Leuven, Sidney Kimmel Comprehensive Cancer Center, University of Manchester, Istanbul University, Kanagawa Cancer Center, University of Sydney, Chungbuk National University, Yonsei University, Nippon Medical School Hospital, Moffitt Cancer Center

#Research Grant #Expert Testimony + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

1459PD - Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export